期刊文献+

老年原发性肺癌患者血管内皮生长因子和细胞角化素蛋白与临床病理特征的关系 被引量:1

Changes of serum levels of vascular endothelial growth factors and CYFRA21-1 in elderly patients with primary lung cancer and their relationship with the clinical pathophysiological characteristics
原文传递
导出
摘要 目的评价老年原发性肺癌患者手术前后血清中血管内皮生长因子(VEGF)和细胞角化素蛋白片段19(CYFRA 21—1)的含量变化及其与肺癌临床病理特征的关系。方法分别用酶联免疫吸附实验(ELISA)法和电发光免疫法(ECLIA)测定54例老年原发性肺癌患者(肺癌组)术前和其中50例术后、34例老年肺良性疾病患者(非癌组)以及30例老年健康者(健康组)血清VEGF和CYFRA21—1含量变化,并分析它们与临床病理特征的关系。结果肺癌组患者手术前血清中VEGF含量(210.45±61.72)ng/L、CYFRA21—1含量(11.86±3.78)μg/L,均显著高于非癌组[(79.56±24.4)ng/L、(2.43±0.78)μg/L]和健康组[(71.81±19.32)ng/L、(2.14±0.65)μg/L],差异均有统计学意义(均为P<0.01)。非癌组血清VEGF和CYFRA21—1含量与健康组比较,差异无统计学意义(P>0.05)。肺癌组手术前血清VEGF和CYFRA21—1含量与肺癌原发肿瘤大小、细胞分化程度、临床TNM分期和有无远处转移密切相关(P<0.05),但与患者的性别、年龄、吸烟史、肿瘤部位及有无淋巴结转移无明显相关(P>0.05),血清VEGF含量与肺癌的组织学类型无关(P>0.05),而CYFRA21—1与组织学类型有关(P<0.01)。手术切除肿瘤后第7~10天,50例中有46例血清VEGF和CYFRA21—1含量下降,手术前后比较,差异有统计学意义(P<0.05),根治性切除患者血清vEGF和cYFRA21-1含量比姑息性切除患者下降幅度更明显(P<0.05)。结论老年原发性肺癌患者存在血清VEGF和CYFRA21—1含量升高,且与肺癌的部分临床病理特征有密切关系,可能是预测肺癌进展程度和判断预后的有用指标。 Objective To evaluate the relationship of the serum levels of vascular endothelial growth factors(VEGF) and CYFRA21-1 with the clinical pathophysiological characteristics in the elderly patients with primary lung cancer. Methods The serum VEGF level was measured by ELISA and serum CYFRA21-1 level was measured by electrochemiluminescence immunoassay (ECLIA). The preoperative serum samples (54 patients)and postoperative serum samples (50 patients) from the elderly patients with primary lung cancer were taken. The 34 elderly patients with benign pulmonary diseases and 30 elderly healthy volunteers were enrolled as controls. Results The preoperative serum levels of VEGF and CYFRA21-1 were significantly higher in elderly patients with lung cancer than with benign pulmonary diseases and elderly healthy volunteers (P〈 0.01). No significant difference was found in the levels of VEGF and CYFRA21-1 between patients with benign pulmonary diseases and healthy volunteers(P〉0.05). The preoperative serum levels of VEGF and CYFRA21-1 in elderly patients with lung cancer were closely associated with the size of the primary tumors, TNM stages, grade of cell differentiation and distant metastasis (P〈0. 05), but not with gender, age, smoking, type of the tumor and lymph node metastasis status (P〉0.05). No correlation was found between the VEGF level and histologic classification of tumors (P 〉 0.05). However, the serum CYFRA21-1 level was related to the histologic classification (P〈0. 01). The serum levels of VEGF and CYFRA21-1 in elderly lung cancer patients were significantly lower on the 7 th and 10 th postoperative day than those before operation (P〈0. 05). Conclusions Elevations of serum of levels VEGF and CYFRA21 1 exist in the elderly patients with lung cancer and are remarkably related with some biological characteristics of tumors. Preoperative and postoperative measurement of serum levels of VEGF and CYFRA21-1 are helpful for the diagnosis and prediction of prognosis in patients with lung cancer.
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2006年第10期738-741,共4页 Chinese Journal of Geriatrics
关键词 肺肿瘤 血管内皮生长因子类 角蛋白 肿瘤标记 生物学 Lung neoplasms Vascular endothelial grouth factors Keratin Tumor markers, biological
  • 相关文献

参考文献8

  • 1Nielsen HJ,Werther K,Mynster T,et al.Bacteriainduced release of white cell and platelet-derived vascular endothelial growth factor in vitro.Vox Sang,2001,80:170-178.
  • 2Cox G,Jones D,Verak AM,et al.Angiogenesis and non-small cell lung cancer.Lung Cancer,2000,27:81-100.
  • 3Ebert W,Muley T.CYFRA21-1 in the follow-up of inoperable non-small cell lung cancer patients treated with chemotherapy.Anticancer Res,1999,19:2669-2672.
  • 4Mall JW,Schwenk W,Philipp AW,et al.Serum vascular endothelial growth factor levels correlate better with tumor stage in small cell lung cancer than albumin,neuron-specific enolase or lactate dehydrogenase.Respirology,2002,7:99-102.
  • 5Brechot JM,Cherret S,Nataf J,et al.Diagnostic and prognostic value of CYFRA21-1 compared with other tumor markers in patients with non-small cell lung cancer:a prospective study of 116 patients.Eur J cancer,1997,33:385-391.
  • 6Yoshi T,Tsub A,Kobayashi O,et al.Plasma concentration of VEGF and bFGF in patients with gastric carcinoma.Cancer Lett,2000,153:7-12.
  • 7Foa P,Fornier M,Miceli R,et al.Tumor markers CEA,NSE,SCC,TPA and CYERA21-1 in resectable non-small cell lung cancer.Anticancer Res,1999,19:3613-3618.
  • 8Kishiro I,Kato S,Fuse D,et al.Clinical significance of vascular endothelial growth facter in patients with primary lung cancer.Respirology,2002,7:93-98.

同被引文献15

  • 1徐爱晖,尹岩伟,陈飞虎.肺癌患者血清内皮抑素水平对肺癌早期诊断价值的研究[J].中华医学杂志,2006,86(27):1916-1918. 被引量:13
  • 2Suzuki M,Iizasa T,Ko E,et al.Serum endostatin correlates with progression and prognosis of nonsmall cell lung cancer.Lung Cancer,2002,35:29-34.
  • 3Folkman J.Tumor angiogenesis:therapeutic implications.NEnglJ Med,1971,285:1182-1186.
  • 4O'Reilly MS,Holmgren L,Shing Y,et al.Angiostatin:a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma.Cell,1994,79:315-328.
  • 5Dvorakh F,Nagyj A,Feng D,et al.Vascular permeability factor/ vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis.Curr Top Microbiol Immunol,1999,237:97-101.
  • 6Demiirkazik A,Akbulut H,Ulgara F,et al.Serum vascular endothelial growth factor levels in patients with non-small cell lung cancer.Ann Saudi Med,2004,24:473-475.
  • 7Shumanuki Y,Takahashi K,Cui R,et al.Role of serum vascular endothelial growth factor in the prediction of angiogenesis and prognosis for non-small cell lung cancer.Lung,2005,183:29-42.
  • 8Hanai J,Gloy J,Karumanchi SA,et al.Endostatin is a potential inhibitor of Wnt signaling.J Cell Biol,2002,158:529-539.
  • 9Kang HY,Shi MD,Kang SS,et al.Proteinkinase B inhibits endostatin-induced apoptosis in HUVECs.J Biochem Mol Biol,2006,39:97-104.
  • 10Feldman AL,Tamakin L,Paciotti GF,et al.Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with stage Ⅳ clear cell renal cancer.Clin Cancer Res,2000,6:4628-4634.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部